Soleno Therapeutics, Inc (SLNO)

Etorro trading 970x250

About Soleno Therapeutics, Inc

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics has collaboration with Vanderbilt University to discover and develop next generation K(ATP) channel activators for the treatment of rare diseases. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California. Address: 203 Redwood Shores Parkway, Redwood City, CA, United States, 94065

Soleno Therapeutics, Inc News and around…

Latest news about Soleno Therapeutics, Inc (SLNO) common stock and company :

24 Stocks Moving in Monday's Pre-Market Session
23 May, 2022 FinancialContent

Gainers Genocea Biosciences, Inc. (NASDAQ: GNCA) shares rose 33.8% to $0.2795 in pre-market trading after declining around 5% on ...

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
20 May, 2022 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Recommends COVID-19 ...

Soleno Therapeutics Announces Presentations at the 2022 European Congress of Endocrinology
19 May, 2022 Yahoo! Finance

REDWOOD CITY, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced presentations at the upcoming 2022 European Congress of Endocrinology (ECE), which is being held May 21-24, 2022, in Milan, Italy. Details of the presentations are as follows: 2022 European Congress of Endocrinology (ECE) Title:DCCR UpdateFormat:Presentation at the I

KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M
17 May, 2022 Yahoo! Finance

KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.

Soleno Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
17 May, 2022 Yahoo! Finance

REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Global Investment Conference, being held May 23-26, 2022, virtually and in Miami, FL. The presentation will be available on-demand beginning at 7 AM Eastern

Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug
12 May, 2022 Yahoo! Finance

The FDA accepts Regulus' (RGLS) IND application for RGLS8429 to treat autosomal dominant polycystic kidney disease. The company plans to begin a phase I study in second-quarter 2022. Stock up.

Catalyst Pharmaceuticals (CPRX) Q1 Earnings Miss, Revenues Up Y/Y
11 May, 2022 Yahoo! Finance

Catalyst's (CPRX) first-quarter 2022 earnings miss estimates while revenues meet the same.

Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
10 May, 2022 Yahoo! Finance

REDWOOD CITY, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update, and reported financial results for the three months ended March 31, 2022. First Quarter 2022 and Recent Corporate Highlights Continuing dialogue with the U.S. Food and Drug Administration (FDA) to obtain alignment on the design of a study to provid

Corcept's (CORT) Q1 Earnings & Revenues Fall Shy of Estimates
06 May, 2022 Yahoo! Finance

Corcept's (CORT) earnings as well as revenues miss estimates in the first quarter of 2022.

Pacira's (PCRX) Q1 Earnings Miss Estimates, Revenues Rise Y/Y
05 May, 2022 Yahoo! Finance

Pacira's (PCRX) earnings fall shy of estimates in the first quarter of 2022 while revenues beat the same.

Zoetis' (ZTS) Q1 Earnings and Revenues Surpass Estimates
05 May, 2022 Yahoo! Finance

Zoetis' (ZTS) earnings and revenues trump estimates in the first quarter of 2022.

Soleno Therapeutics Announces Presentation of Long-Term Hyperphagia and Behavioral Data in Patients Receiving DCCR for Treatment of Prader-Willi Syndrome
02 May, 2022 Yahoo! Finance

Results Show Significant Improvements in Hyperphagia and PWS-Related Behaviors in DCCR-Treated Patients Presentations at the Pediatric Academic Societies 2022 Virtual Annual Meeting and Pediatric Endocrinology Society 2022 Virtual Annual Meeting REDWOOD CITY, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced two presentations hig

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
25 Apr, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Another day of investing awaits for traders as we start it off with a breakdown of the biggest pre-market stock movers for Monday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

High school seniors saw a problem — so they started a biotech company
13 Apr, 2022 Yahoo! Finance

It started with hearing a podcast about Duchenne muscular dystrophy and progressed through an 11th grade biology class project. Now Shivin Kumar and Malyka Ram's Uplands Med is starting experiments at a San Carlos incubator.

How Covid stymied a Peninsula company's drug aimed at calming insatiable appetites
11 Apr, 2022 Yahoo! Finance

A small Redwood City company's drug was working in a late-stage clinical trial in a devastating genetic disease that causes overeating. Then it didn't. A key researcher and the company blame a change in eating habits brought on by Covid.

12 Health Care Stocks Moving In Wednesday's After-Market Session
06 Apr, 2022 FinancialContent

Gainers HTG Molecular Diagnostics (NASDAQ:HTGM) stock rose 35.1% to $1.73 during Wednesday's after-market session. At the close, HTG ...

Soleno Therapeutics Announces Closing of Approximately $15 Million Underwritten Public Offering
01 Apr, 2022 Yahoo! Finance

REDWOOD CITY, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the closing of an underwritten public offering of 40,000,000 shares of its common stock at a public offering price of $0.25 per share and, for certain investors, in lieu of common stock, pre-funded warrants to purchase 20,000,000 shares of its common stock at a publi

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
31 Mar, 2022 Yahoo! Finance

REDWOOD CITY, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update and announced financial results for the fourth quarter and full-year ended December 31, 2021. Fourth Quarter 2021 and Recent Corporate Highlights Received official meeting minutes on January 20, 2022, from the December 21, 2021, Type C meeting with

53 Biggest Movers From Yesterday
30 Mar, 2022 FinancialContent

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM ...

12 Health Care Stocks Moving In Tuesday's Intraday Session
29 Mar, 2022 FinancialContent

Gainers IGM Biosciences (NASDAQ:IGMS) shares rose 114.8% to $32.2 during Tuesday's regular session. IGM ...

36 Stocks Moving In Tuesday's Mid-Day Session
29 Mar, 2022 FinancialContent

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday. McCormick (NASDAQ: ...

Stocks That Hit 52-Week Lows On Tuesday
29 Mar, 2022 FinancialContent

On Tuesday, 81 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Grupo Aval Acciones ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
29 Mar, 2022 FinancialContent

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock moved upwards by 45.0% to $0.29 during Tuesday's pre-market session. The ...

Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
29 Mar, 2022 Yahoo! Finance

REDWOOD CITY, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the pricing of an underwritten public offering of 40,000,000 shares of its common stock at a public offering price of $0.25 per share and, for certain investors, in lieu of common stock, pre-funded warrants to purchase 20,000,000 shares of its common stock at a publi

20 Stocks Moving in Tuesday's Pre-Market Session
29 Mar, 2022 FinancialContent

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) rose 40.1% to $21.00 in pre-market trading following announcement of collaboration ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
29 Mar, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! It's time to start another busy day of trading with another breakdown of the biggest pre-market stock movers on Tuesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Get in Now on Tiny $3 ‘Forever Battery’ Stock It doesn’t matter if you have $500 in savings or $5 million. Do this now. Stock Prodigy Who Found NIO at $2… Says Buy THIS Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Soleno Therapeutics Announces Proposed Underwritten Public Offering
28 Mar, 2022 Yahoo! Finance

REDWOOD CITY, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering and, in lieu of common stock, Soleno intends to offer and sell to certain investors pre-funded warrants to purchase shares of its common stock. Each share of common stock

Here's Why Soleno Therapeutics (NASDAQ:SLNO) Must Use Its Cash Wisely
27 Mar, 2022 Yahoo! Finance

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

12 Health Care Stocks Moving In Monday's After-Market Session
14 Mar, 2022 FinancialContent

Gainers Sigilon Therapeutics (NASDAQ:SGTX) stock rose 15.5% to $1.49 during Monday's after-market session. The market value of their ...

Stocks That Hit 52-Week Lows On Monday
14 Mar, 2022 FinancialContent

On Monday, 671 companies achieved new lows for the year. Points of Interest From Today's 52-Week ...

Soleno Therapeutics, Inc (SLNO) is a NASDAQ Common Stock listed in , ,

970x250